Latest close
$417.57
As of Oct 2, 2026
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| First Pacific Advisors | 7.85% | 1,598,506 | TRIMMED (-7.2%) |
| AKO Capital | 5.71% | 616,881 | TRIMMED (-40.1%) |
| Cantillon Capital Management | 5.26% | 88,014 | TRIMMED (-95.4%) |
| Markel Group | 3.02% | 999,671 | TRIMMED (-2.3%) |
| Weitz Investment Management | 2.34% | 85,225 | TRIMMED (-19.9%) |
| Giverny Capital | 1.25% | 93,310 | TRIMMED (-45.4%) |
| Causeway Capital Management | 0.61% | 142,050 | TRIMMED (-29.6%) |
| Brave Warrior Advisors | 0.01% | 612 | NEW |
| Maverick Capital | 0.01% | 2,704 | NEW |
| Dodge & Cox Funds | 0.00% | 19,210 | TRIMMED (-4.1%) |
| Mairs & Power Funds | 0.00% | 509 | TRIMMED (-21.5%) |
Source: SEC Form 13F filings for the quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. 13F filings cover long positions only and arrive up to 45 days after quarter-end.
Exited this quarter: First Eagle Investment Management.
| Institutions holding | 2,289 of 8,857 filers |
| Long-only filers among them | 2,279 |
| Change vs 2026 Q1 | +189 net · 1,769 entered · 1,580 exited |
| Shares reported, all filers | 438,163,853 |
| Reported value, all filers | $170.3B |
Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).
0 insiders bought on the open market in the last 90 days (0 purchases, $0), against 59 sales by 4 insiders ($17.2M).
Source: SEC Form 4 filings, as of Oct 3, 2026. Open-market transactions only.
1 House members reported buying (1 purchases vs 4 sales). Bought by Democrats. Latest buy: May 19, 2026.
Source: U.S. House Clerk STOCK Act periodic transaction reports, as of Oct 3, 2026. Reported amounts are ranges, and reports can arrive up to 45 days after the trade. Senate reports are not included yet.
Politicians
· Bought by Members — Last 6 months: bought by a U.S. House member
Financial Screens
· Graham — Sound finances and a long run of profits
· Dividend Growth — Dividends raised for more than 10 years
· Earnings Quality (Cash Conversion) — Profits that actually come back as cash
· Earnings Stability — Small earnings swings and almost no loss years
Chart Signals
· Monthly Uptrend — Price above its 12-month moving average
· Top Relative Strength — Top 20% of the universe by 6-month return
Key figures
· Graham — Current ratio: 2.19 · Straight profitable years: 17 · Debt ratio: — · Latest net income: $2.3B
· Dividend Growth — Dividend per share: 3.89 · Dividend yield: 0.9% · Straight dividend years: 19 · 10-yr dividend growth: 134.3%
· Earnings Quality (Cash Conversion) — Cash conversion (3-yr avg): 1.98 · Operating cash flow: $4.8B · Net income: $2.3B
· Earnings Stability — Earnings variation (CV): 0.45 · Loss years (of 10): 0 · Latest net income: $2.3B
· Bought by Members — Members buying: 1 · Buy txns: 1 · Sell txns: 4 · Latest buy: May 19, 2026
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
· Super-investor 13F BEST — appeared in 5 of the last 20 quarterly lists; latest 2026 Q2, ranked #39 of 50.
· Insider BEST — appeared in 1 of the last 20 quarterly lists; latest 2021 Q4, ranked #50 of 50.
· Politician BEST — appeared in 7 of the last 20 quarterly lists; latest 2025 Q2, ranked #44 of 50.
| 13F signal (2021 Q3 – 2026 Q1) | Events | Win rate | Avg return | SPY | Excess |
|---|---|---|---|---|---|
| Heavy accumulation — 3+ tracked funds increased together | 12 | 41.7% | +4.8% | +3.5% | +1.2% |
| Share count tripled (3x) | 1 | 100.0% | +0.2% | +1.9% | -1.7% |
Measured from SEC 13F filings: entry at the close on the first trading day after each quarter’s filing deadline, exit one quarter later on the same rule, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.
Open this in the GetCoattail app →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.